Differential Risks for Melanoma: p16 and DNA Repair
NCT00615095 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 323
Last updated 2011-04-20
Summary
The goal of this study is to find out if some people are more likely to get melanoma, a form of skin cancer, than others. People respond to the environment in different ways. Some may be born with genes that make them more likely to get this type of skin cancer. Genes are made up of DNA. DNA damage is one of the first steps in developing cancer. Each person has many ways to repair normal damage to their genes. Some people may have a lower level of this repair and that may make them more likely to get cancer. Some genes are important for DNA repair. The genes we want to test are thought to affect the rate at which DNA can be repaired. We also want to find out if sun habits are related to these levels of DNA repair or genetic mutations.
Conditions
- Melanoma
- Skin Melanoma
Interventions
- OTHER
-
self-administered questionnaire and blood draw
Epidemiologic data will be collected via a self-administered questionnaire which will be distributed to subjects by a member of the study staff. It should take less than fifteen minutes to complete, and subjects will have the options of completing it at the time of their blood-drawing or filling it out at home and mailing it back to the study staff.
- OTHER
-
self-administered questionnaire and blood draw
Epidemiologic data will be collected via a self-administered questionnaire which will be distributed to subjects by a member of the study staff. It should take less than fifteen minutes to complete, and subjects will have the options of completing it at the time of their blood-drawing or filling it out at home and mailing it back to the study staff.
- OTHER
-
health questionnaire, blood draw and skin exam
Numbers will be randomly selected from a pool of prefixes. Numbers will be screened by computer for being working, non-business, non-fax, and non-modem numbers. After establishing eligibility for the study, we will send the potential control a letter further explaining the purpose of the study and its requirements. An interviewer will then call to arrange an appointment. During the interview, the subject will sign informed consent, be given the public health questionnaire, have 30 ml of blood drawn, and undergo the skin examination of arms and back.
Sponsors & Collaborators
-
University of New Mexico
collaborator OTHER -
Yale University
collaborator OTHER -
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Irlene Orlow, PH.D., M.S. · Memorial Sloan Kettering Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1997-02-28
- Primary Completion
- 2011-04-30
- Completion
- 2011-04-30
Countries
- United States
Study Locations
More Related Trials
-
Using MC1R Genotype to Impact Melanoma Risk Behavior
NCT03509467 ·Status: COMPLETED ·Phase: NA
-
S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma
NCT00898183 ·Status: COMPLETED
-
Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members
NCT00346008 ·Status: COMPLETED
-
Skin Health Online for Melanoma: Better Risk Assessment
NCT03130569 ·Status: COMPLETED ·Phase: NA
-
Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting
NCT05079113 ·Status: COMPLETED
-
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer
NCT03922893 ·Status: RECRUITING
-
Risk Information and Skin-cancer Education for Undergraduate Prevention
NCT03979872 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma
NCT00049010 ·Status: COMPLETED ·Phase: NA
-
Natural History Study of Moles and Suspicious Melanoma
NCT00288938 ·Status: COMPLETED
-
Understanding the Transition from Normal Melanocytes to Nevus to Melanoma
NCT06605417 ·Status: RECRUITING
-
Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma
NCT00588198 ·Status: COMPLETED
-
Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
NCT01209299 ·Status: COMPLETED
-
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
NCT00897481 ·Status: UNKNOWN
-
The Registry Study of Genetic Alterations of Melanoma in Taiwan
NCT06952400 ·Status: RECRUITING
-
Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
NCT00004153 ·Status: COMPLETED ·Phase: NA
-
Melanoma: Genomic Profiles, Molecular Markers and Therapeutic Implications
NCT05119829 ·Status: UNKNOWN
-
Rare Tumors and Cancer Predisposition in Individuals and Families
NCT05350761 ·Status: RECRUITING
-
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
NCT06608511 ·Status: RECRUITING
-
MElanoma Research Lymph Node Prediction Implementation National_001
NCT04759781 ·Status: ACTIVE_NOT_RECRUITING
-
In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin
NCT00588315 ·Status: ACTIVE_NOT_RECRUITING
-
Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT02105168 ·Status: UNKNOWN ·Phase: NA
-
Skin Cancer Screening Education Study
NCT02352428 ·Status: UNKNOWN ·Phase: NA
-
Melanoma Detection by Oblique-Incidence Optical Spectroscopy
NCT00526032 ·Status: COMPLETED
-
Study of DNA Samples From Patients With Multiple Myeloma
NCT00898040 ·Status: COMPLETED
-
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
NCT00685750 ·Status: TERMINATED ·Phase: NA